Physician profile
Donna L Quesada
NPI 1972548238
$301.06
in general payments reported to CMS, 2019-2025
11 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $21.55 · 2023: $109 · 2024: $70.47 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $52.92 | 2025 | Euflexxa |
| Depuy Synthes Sales INC. | $51.03 | 2022-2025 | Orthovisc, Peak, Monovisc |
| Pacira Pharmaceuticals Incorporated | $45.74 | 2023-2024 | Zilretta, Iovera |
| Smith+Nephew, INC. | $27.54 | 2023 | Bone Anchors With Arthroscopic Delivery System |
| Radius Health, INC. | $24.03 | 2023 | Tymlos |
| Ibsa Pharma INC. | $21.18 | 2023 | Licart, Tirosint |
| Pfizer INC. | $18.20 | 2024 | |
| Almatica Pharma LLC | $17.65 | 2025 | Teriparatide |
| Ani Pharmaceuticals, INC. | $16.09 | 2024 | Purified Cortrophin Gel |
| Ethicon US, LLC | $15.48 | 2023 | Vistaseal, Stratafix, Ethicon |
| Electronic Waveform Lab, INC. | $11.20 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Quesada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.